Showing results (91-100 of 205) with videos related to
Sort By:
Pageof 21
Developmental Neurobiology|May 25, 2012
Neuroimmune mechanisms in fetal alcohol spectrum disorderCynthia J M Kane, Kevin D Phelan, Paul D DrewNeuroimage|February 5, 2008
Parietal activation during retrieval of abstract and concrete auditory informationEllen C Klostermann, Ari J M Kane, Arthur P ShimamuraOphthalmic Epidemiology|January 29, 2000
Photoscreening for amblyogenic factors by public health personnel: the Eyecor Camera SystemR W Enzenauer, H L Freeman, M R Larson, et al.Psychopharmacology Bulletin|January 1, 1990
Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserinC H Miller, W W Fleischhacker, H Ehrmann, et al.The American Surgeon|July 1, 1990
Needle aspiration of nonfunctioning parathyroid cystsR A Prinz, J R Peters, J M Kane, et al.Neuroscience Letters|December 8, 1995
The enhancement of muscimol-stimulated 36C1 influx by the antispastic 5-aryl-3-(alkylsulfonyl)-4H-1,2,4-triazole (MDL 27,531) in rat brain membrane vesiclesJ A Miller, D Braun, P A Chmielewski, et al.Journal of Clinical Psychopharmacology|October 1, 1982
A prospective study of tardive dyskinesia development: preliminary resultsJ M Kane, M Woerner, P Weinhold, et al.The Journal of Clinical Psychiatry|May 1, 1983
Safety and efficacy of bupropion in elderly patients: preliminary observationsJ M Kane, K Cole, S Sarantakos, et al.Psychopharmacology|January 1, 1982
Prevalence of abnormal involuntary movements ("spontaneous dyskinesias") in the normal elderlyJ M Kane, P Weinhold, B Kinon, et al.Die Pharmazie|April 1, 1992
Synthesis and pharmacology of 3-aryl-5,6-dihydro-6-oxo-1(4H)-pyridazineacetic acid derivativesJ M Kane, E W Huber, F P Miller, et al.Pageof 21